Considering the totality of evidence from clinical trials, post-marketing reports and observational studies, alongside the generally low incidence rate of NAION, Novo Nordisk believes that the benefit-risk profile of semaglutide remains favorable, the spokesperson said.
Dr Ren-Fielding is unconvinced
M1 microglia release neurotoxic and inflammatory factors such as IL-6, IL-1, and TNF-, contributing to neuronal damage and death, while M2 microglia secrete neurotrophic factors including BDNF, IL-4, and IL-10, fostering neuronal growth and protection (51)
SchmidtRLuboeinskiTMarkartPRuppertCDaumCGrimmingerFet alAlveolar antioxidant status in patients with acute respiratory distress syndrome
Environ Pollut 279:116938